Integral Diagnostics Limited
ITGDF
$1.00
-$1.06-51.41%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.29% | 19.18% | 6.90% | 6.13% | 3.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.29% | 19.18% | 6.90% | 6.13% | 3.80% |
| Cost of Revenue | 33.43% | 20.65% | 7.72% | 6.54% | 3.76% |
| Gross Profit | 26.82% | 16.10% | 5.17% | 5.28% | 3.88% |
| SG&A Expenses | 27.02% | 16.66% | 6.10% | 5.47% | 3.22% |
| Depreciation & Amortization | 18.67% | 11.93% | 4.98% | 5.72% | 4.97% |
| Other Operating Expenses | 26.37% | 29.21% | 33.47% | 9.20% | -9.40% |
| Total Operating Expenses | 30.95% | 19.06% | 7.01% | 6.05% | 3.51% |
| Operating Income | 34.75% | 20.42% | 5.76% | 6.95% | 6.77% |
| Income Before Tax | 119.85% | 118.39% | 117.08% | -115.60% | -280.90% |
| Income Tax Expenses | 86.01% | 26.64% | -22.15% | -30.71% | -37.86% |
| Earnings from Continuing Operations | 107.68% | 108.72% | 109.91% | -69.91% | -335.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 107.45% | 108.60% | 109.91% | -69.91% | -335.28% |
| EBIT | 34.75% | 20.42% | 5.76% | 6.95% | 6.77% |
| EBITDA | 27.74% | 11.97% | -2.96% | -2.02% | -2.42% |
| EPS Basic | 104.53% | 107.12% | 109.93% | -70.67% | -334.81% |
| Normalized Basic EPS | -9.22% | 19.59% | 100.00% | 26.94% | -1.92% |
| EPS Diluted | 104.53% | 107.11% | 109.89% | -67.32% | -338.76% |
| Normalized Diluted EPS | -10.89% | 18.85% | 101.53% | 28.51% | -0.56% |
| Average Basic Shares Outstanding | 31.32% | 17.29% | 3.23% | 1.79% | 0.33% |
| Average Diluted Shares Outstanding | 32.86% | 17.67% | 2.55% | 0.78% | -0.97% |
| Dividend Per Share | 9.71% | 2.57% | -4.25% | -4.49% | -5.69% |
| Payout Ratio | 17.94% | 13.36% | 9.96% | 0.46% | -1.40% |